Management of Diabetes Mellitus in the Elderly

Shovie Thalia Miranda, Eva Niamuzisilawati

Abstract

Introduction: Due to increasing life expectancy and lifestyle changes, the prevalence of diabetes among the elderly is rising, along with the associated public health burden. Diabetes management in this population is complicated by age-related physiological changes, sarcopenia, comorbidities, and varying degrees of functional and cognitive abilities that contribute to frailty.

Methods: This narrative review examines the unique characteristics and complex challenges of managing diabetes in the elderly. It synthesizes recent literature and clinical guidelines to recommend a comprehensive yet personalized management strategy that accounts for the heterogeneity of this patient group.

Results: Elderly patients with diabetes often face multiple chronic conditions that increase their risk of cardiovascular disease, cancer, and mortality. They are also more vulnerable to severe acute complications such as hyperosmolar hyperglycemic state and hypoglycemia. Optimal management involves a holistic assessment of functional and cognitive status, nutritional state, and the presence of geriatric syndromes. This assessment guides the individualization of glycemic targets, which are often less stringent than in younger adults. Therapeutic choices should prioritize agents with a low risk of hypoglycemia and consider the patient's comorbidities, polypharmacy, and overall quality of life.

Conclusions: A personalized, patient-centered approach is essential to reduce morbidity and mortality in geriatric patients with diabetes. Optimal management, which includes ongoing education, regular screening for complications and geriatric syndromes, and multidisciplinary supervision, is critical for maintaining functional independence and improving health outcomes

Keywords

Diabetes Mellitus; Elderly; Multimorbidity; Sarcopenia

Full Text:

PDF

References

Remelli F, Ceresini MG, Trevisan C, Noale M, Volpato S. Prevalence and impact of polypharmacy in older patients with type 2 diabetes. Aging Clin Exp Res. 2022;34:1969-83.

Milanesi A, Weinreb JE. Diabetes in the Elderly. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2020.

PERKENI. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2019. Jakarta: PB PERKENI; 2019.

Yun JS, Kim K, Ahn YB, Han K, Ko SH. Holistic and personalized strategies for managing in elderly type 2 diabetes patients. Diabetes Metab J. 2024;48(4):531-45.

Bellary S, Kyrou I, Brown JE, Bailey CJ. Type 2 diabetes mellitus in older adults: clinical considerations and management. Nat Rev Endocrinol. 2021;17:534-48.

Chung SM, Moon JS, Chang MC. Prevalence of sarcopenia and its association with diabetes: a meta-analysis of community-dwelling Asian population. Front Med (Lausanne). 2021;8:681232.

American Diabetes Association. Standards of Medical Care in Diabetes-2025. Chapter 13: Older Adults. Diabetes Care. 2025;48(Suppl 1).

International Diabetes Federation. Managing Older People with Type 2 Diabetes: IDF Global Guideline for Managing Older People with Type 2 Diabetes. Brussels: IDF; 2023.

Guo L, Xiao X, et al. Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition). Aging Medicine (Milton). 2024;7(1):5-51.

Sanz-Canovas J, Lopez-Sampalo A, Cobos-Palacios L, Ricci M, Hernandez-Negrin H, Mancebo-Sevilla JJ, et al. Management of type 2 diabetes mellitus in elderly patients with frailty and/or sarcopenia. Int J Environ Res Public Health. 2022;19:8677.

Tao J, Ke Y-Y, Zhang Z, et al. Comparison of the value of malnutrition and sarcopenia for predicting mortality in hospitalized old adults over 80 years. Exp Gerontol. 2020;138:111007.

American Geriatrics Society Beers Criteria Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71:2052-81.

Pilla SJ, Pitts SI, Maruthur NM. High concurrent use of sulfonylureas and antimicrobials with drug interactions causing hypoglycemia. J Patient Saf. 2022;18:e217-24.

Karagiannis T, Tsapas A, Athanasiadou E, et al. GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2021;174:108737.

Ata F, Yousaf Z, Khan AA, et al. SGLT-2 inhibitors associated euglycemic and hyperglycemic DKA in a multicentric cohort. Sci Rep. 2021;11:10293.

Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 19th ed. New York: McGraw Hill Education; 2015.

International Diabetes Federation. Managing Older People with Type 2 Diabetes: IDF Global Guideline for Managing Older People with Type 2 Diabetes. Brussels: IDF; 2023.

Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, Goisser S, Hooper L, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr. 2018;38:10-47.

Perkumpulan Endokrinologi Indonesia (PERKENI). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2024. Jakarta: PB PERKENI; 2024.

Guo L, Xiao X, et al. Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition). Aging Medicine (Milton). 2024;7(1):5-51.

Refbacks

  • There are currently no refbacks.